It is a pharma private limited company based in Patna, Bihar, India, established in 2016.
2016 | Patna, Bihar, India | ActiveNeophyte Pharmaceuticals Private Limited, a active private limited company, was established on 13 May 2016 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999BR2016PTC031554. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Satyendra Kumar (Director), Chandresh Kumar (Director), Rohit Kumar (Director). Past directors included Megha, Ravi Anand, Anuja Kumari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Prahlad Vishwakarma, Vishwa Enterprises, Bander Bagicha, Frazer Road,, Patna, Bihar, 800001.
U74999BR2016PTC031554
031554
13 May 2016
₹1.00 M
₹1.00 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Neophyte Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyendra Kumar | Director | 14 Mar 2018 | Current |
| Chandresh Kumar | Director | 14 Mar 2018 | Current |
| Rohit Kumar | Director | 14 Mar 2018 | Current |
| Preeti Singh | Director | 13 May 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Mar 2018 | Past |
| Pramod Abcsdd | Director | 15 Mar 2018 | Past |
| Pramod Abcsdd | Director | 15 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neophyte Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 19.1% decrease. The company also saw a substantial fall in profitability, with a 1152.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Neophyte Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neophyte Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neophyte Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neophyte Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Neophyte Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Neophyte Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was documented.
Satyendra Kumar was appointed as a Director was appointed as a Director on 14 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Chandresh Kumar was appointed as a Director was appointed as a Director on 14 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Rohit Kumar was appointed as a Director was appointed as a Director on 14 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Preeti Singh was appointed as a Director was appointed as a Director on 13 May 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
The CIN of Neophyte Pharmaceuticals Private Limited is U74999BR2016PTC031554.
Neophyte Pharmaceuticals Private Limited is headquartered at C/O Prahlad Vishwakarma, Vishwa Enterprises, Bander Bagicha, Frazer Road,, Patna, Bihar, 800001.
Neophyte Pharmaceuticals Private Limited was incorporated on 13 May 2016.
The current directors of Neophyte Pharmaceuticals Private Limited are
The primary industry of Neophyte Pharmaceuticals Private Limited is Trade.
Neophyte Pharmaceuticals Private Limited is unlisted.
The authorized capital of Neophyte Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Neophyte Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX